All Type of News
Start of low-charge ‘T-money service’ at pharmacies
‘T-money card,’ that is well known as transportation card or electronic cash, will be available at pharmacies.
On the 6th, the Korean Pharmaceutical Association(President Chan-Hwi Cho) announced nationwide extension ...
MFDS designates renal cell carcinoma therapy ‘cabozantinib’ as orphan drug
‘Cabozantinib,’ a progressive renal cell carcinoma treatment, will be designated as orphan drug.
The Ministry of Food and Drug Safety(MFDS) will make a pre-announcement of the ‘Partial Amendment to the Regulation for...
LG Chem recruits Ji-Woong Sohn, former CMO at Hanmi, as Head-Life Science
In order to actively nurture itself in the red biotechnology field, LG Chem will recruit Vice President Ji-Woong Sohn(53), a former CMO(Chief Medical Officer) and Head-New Drug at Hanmi Pharm, as Head-Life Science Dep...
Continuous conflicts among pharmacy, distribution and pharmacy over return of stock drugs
Conflicts among pharmacies, wholesalers and pharmaceutical manufactuers have never stopped over the return issue of stocked drugs, which has continued since the separation of drug prescribing and dispensing.
It was o...
1,140 pharmaceutical products newly tested for bioequivalence last year
Last year, there were 1,140 pharmaceutical products which were bioequivalently tested.
According to the Ministry of Food and Drug Safety, the number of pharmaceutical products that were officially recognized with bio...
Chong Kun Dang’s frightening upturn to KRW 1 trillion sales
With the uptrend, Chong Kun Dang is getting very close to KRW 1 trillion sales.
In the 2016 Business Result Announcement(tentative), Chong Kun Dang announced to record KRW 832 billion sales in 2016. The amount is sig...
What are strategic considerations for IPR in U.S. pharmaceutical and biotechnology fields?
A filing procedure, called Inter Partes Review(IPR), conducted to review the patentability in a technology patent registered in the U.S. pharmaceutical and biotechnology market, is conducted by a law body of the U.S. ...
Green Cross signs Korean distribution agreement of ‘Diterin Tab’ with Alvogen Korea
On the 2nd, Green Cross(CEO Eun-Cheol Huh) announced an Korean distribution agreement of the phenylketonuria treatment ‘Diterin Tab’ with Alvogen Korea(CEO Young0Hee Jang).
Under the agreement, Green Cross will take ...
It is dangerous to neglect ‘epilepsy’ while No. of patients decreases
According to the analysis result of big data for health insurance conducted by the National Health Insurance Service(President Sang-Cheol Sung), the number of patients treated for ‘epilepsy(G40-G41)’ was decreased(2.5...
Korean ICT-based medical device market grew KRW 14 trillion by 2020
On the 2nd, the Ministry of Food and Drug Safety(MFDS) announced to publish the prospect and analysis report for medical devices, which contains the current state and trend of the new way of technology fusion and comb...
